Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Hereditary Cancer in Clinical Practice

Hereditary Cancer in Clinical Practice

Hereditary Cancer in Clinical Practice

Editor-in-Chief: J. Lubinski; R. Scott

ISSN: 1897-4287 (electronic version)

Journal no. 13053

BioMed Central

Open access BioMed Central
  • Official journal of the International Hereditary Cancer Center (IHCC)
  • Published under the auspices of the Union for International Cancer Control (UICC)
  • High author satisfaction

Hereditary Cancer in Clinical Practice welcomes authors from all geographically and economically diverse backgrounds to submit to us as the official journal of the Hereditary Cancer Cancer Center (IHCC).  All authors submitting to the journal are eligible for partial coverage of the article-processing charge (APC).  We pride ourselves on our high author satisfaction, and welcome original research articles or literature reviews on any aspect of inherited predispositions to cancer, as well as the epidemiology, counseling, and clinical therapies associated with hereditary cancers.

Related subjects » Cancer Research - Human Genetics - Oncology & Hematology

Impact Factor: 1.59 (2016) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), PubMedCentral, SCOPUS, Google Scholar, Academic OneFile, CNKI, EBSCO Biomedical Reference Collection, EBSCO STM Source, EBSCO TOC Premier, Expanded Academic, Health Reference Center Academic, OCLC, Summon by ProQuest, Thomson Reuters (ISI)

Read This journal on BioMed Central

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 1.590
  • Aims and Scope

    Aims and Scope


    Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies.

    Cancergenetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care.

    Topics covered by the journal include but are not limited to:

    • Original research articles on any aspect of inherited predispositions to cancer.
    • Reviews of inherited cancer predispositions.
    • Application of molecular and cytogenetic analysis to clinical decision making.
    • Clinical aspects of the management of hereditary cancers.
    • Genetic counselling issues associated with cancer genetics.
    • The role of registries in improving health care of patients with an inherited predisposition to cancer.
  • Submit Online
  • English Language Editing

    English Language Editing


  • Writing Resources: Training for Authors